Entecavir hydrate 209216-23-9 CAS NO.209216-23-9

entecavir , entecavir,

entecavir abbreviated etv, is an oral antiviral drugused in the treatment of hepatitis b infection. it is marketed under the trade names baraclude (bms) and entaliv (drl).

entecavir , entecavir,

entecavir abbreviated etv, is an oral antiviral drugused in the treatment of hepatitis b infection. it is marketed under the trade names baraclude (bms) and entaliv (drl).

entecavir , entecavir,

entecavir abbreviated etv, is an oral antiviral drugused in the treatment of hepatitis b infection. it is marketed under the trade names baraclude (bms) and entaliv (drl).

entecavir is a nucleoside analog^[1] (more specifically, a guanosineanalogue) that inhibits reverse transcription, dna replication andtranscription in the viral replication process. the drug's manufacturer claims that entecavir is more efficacious than previous agents used to treat hepatitis b (lamivudine and adefovir).